1. CD 133+ and CXCR4+ colon cancer cells as a marker for lymph node metastasis
   Jennifer Silinsky et al, 2013, Journal of Surgical Research CrossRef
2. The expression of chemokine receptors CXCR3 and CXCR4 in predicting postoperative tumour progression in stages I-II colon cancer: a retrospective study
   Changzheng Du et al, 2014, BMJ Open CrossRef
3. Establishment of Highly Tumorigenic Human Colorectal Cancer Cell Line (CR4) with Properties of Putative Cancer Stem Cells
   Rebecca A. Rowehl et al, 2014, PLoS ONE CrossRef
4. CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
   Shicai Chen et al, 2013, PLoS ONE CrossRef
5. CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis
   Yang Zhao et al, 2016, Oncotarget CrossRef
6. Genetic Basis of Metastasis
   Catherine A. Moroski-Erkul et al, 2019, International Manual of Oncology Practice CrossRef
7. Prognostic Value of Stem Cell Quantification in Stage II Colon Cancer
   Maria Angeles Vaz et al, 2014, PLoS ONE CrossRef
8. High expression of CD133 – stem cell marker for prediction of clinically agressive type of colorectal cancer
   Ognen Kostovski et al, 2020, Polish Journal of Surgery CrossRef
9. Genetic Basis of Metastasis
   Catherine A. Moroski-Erkul et al, 2015, International Manual of Oncology Practice CrossRef
10. Prognostic significance of CD133 and ezrin expression in colorectal carcinoma
    Anan Fathi et al, 2017, IUBMB Life CrossRef
11. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers
    Venkat R. Katkoori et al, 2015, Oncotarget CrossRef
12. Expression of CXCR-4 and IDO in human colorectal cancer: An immunohistochemical approach
    Masaichi Ogawa et al, 2017, Molecular and Clinical Oncology CrossRef
13. Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology
    Lun Kelvin Tsou et al, 2018, Medicinal Research Reviews CrossRef
14. Halting metastasis through CXCR4 inhibition
    Deborah M. Ramsey et al, 2013, Bioorganic & Medicinal Chemistry Letters CrossRef
15. CXCR4 over-expression and survival in cancer: A system review and meta-analysis
    Hongli Zhao et al, 2015, Oncotarget CrossRef
16. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis
    Yao-ping Li et al, 2017, Tumor Biology CrossRef
17. Molecular characteristics of colorectal serrated polyps and hyperplastic polyps
    Otgontuya Sambuudash et al, 2016, Medicine CrossRef
18. Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients
    Zhou Bin et al, 2014, Journal of Surgical Research CrossRef
19. Ping-Pong—Tumor and Host in Pancreatic Cancer Progression
    Wei Mu et al, 2019, Frontiers in Oncology CrossRef
20. Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
    Johanna Fellhofer-Hofer et al, 2024, International Journal of Molecular Sciences CrossRef
21. Expression of the stem cell marker CD133 is related to tumor development in colorectal carcinogenesis
    Shinsuke Kazama et al, 2018, Asian Journal of Surgery CrossRef
22. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta‐analysis
    Shunzeng Lv et al, 2014, Histopathology CrossRef
23. CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients
    Rongyong Huang et al, 2018, Medicine CrossRef
24. Stem Cell Markers CXCR-4 and CD133 Predict Aggressive Phenotype and Their Double Positivity Indicates Poor Prognosis of Oral Squamous Cell Carcinoma
    Ravindran Caspa Gokulan et al, 2021, Cancers CrossRef
25. Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
    Ke Wang et al, 2012, BMC Cancer CrossRef